{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T18:05:16Z","timestamp":1791396316934,"version":"4.3.3"},"reference-count":19,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"vor","delay-in-days":2958,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1038\/mt.2008.143","type":"journal-article","created":{"date-parts":[[2008,7,15]],"date-time":"2008-07-15T14:47:40Z","timestamp":1216133260000},"page":"1637-1642","source":"Crossref","is-referenced-by-count":156,"title":["The Targeted Oncolytic Poxvirus JX-594 Demonstrates Antitumoral, Antivascular, and Anti-HBV Activities in Patients With Hepatocellular Carcinoma"],"prefix":"10.1016","volume":"16","author":[{"given":"Ta-Chiang","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taeho","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byeong-Ho","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David H","family":"Kirn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/mt.2008.143_bib1","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/ncponc0736","article-title":"Clinical trial results with oncolytic virotherapy: a century of promise, a decade of progress","volume":"4","author":"Liu","year":"2007","journal-title":"Nat Clin Pract Oncol"},{"key":"10.1038\/mt.2008.143_bib2","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/sj.mt.6300108","article-title":"History of oncolytic viruses: genesis to genetic engineering","volume":"15","author":"Kelly","year":"2007","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2008.143_bib3","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/nrc1750","article-title":"Recent progress in the battle between oncolytic viruses and tumours","volume":"5","author":"Parato","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"10.1038\/mt.2008.143_bib4","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1158\/0008-5472.CAN-06-2871","article-title":"Systemic efficacy with oncolytic virus therapeutics: clinical proof-of-concept and future directions","volume":"67","author":"Liu","year":"2007","journal-title":"Cancer Res"},{"key":"10.1038\/mt.2008.143_bib5","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.1172\/JCI32727","article-title":"Rational strain selection and engineering creates a broad-spectrum, systemically effective oncolytic poxvirus, JX-963","volume":"117","author":"Thorne","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1038\/mt.2008.143_bib6","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1038\/sj.mt.6300215","article-title":"Targeted inflammation during oncolytic virus therapy severely compromises tumor blood flow","volume":"15","author":"Breitbach","year":"2007","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2008.143_bib7","doi-asserted-by":"crossref","first-page":"13836","DOI":"10.1016\/S0021-9258(17)36723-6","article-title":"Different regulation of thymidine kinase during the cell cycle of normal versus DNA tumor virus-transformed cells","volume":"269","author":"Hengstschl\u00e4ger","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1038\/mt.2008.143_bib8","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ymthe.2006.05.008","article-title":"Systemic armed oncolytic and immunologic therapy for cancer with JX-594, a targeted poxvirus expressing GM-CSF","volume":"14","author":"Kim","year":"2006","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2008.143_bib9","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S1470-2045(08)70107-4","article-title":"Use of a targeted oncolytic poxvirus, JX-594, in patients with refractory primary or metastatic liver cancer: a phase I trial","volume":"9","author":"Park","year":"2008","journal-title":"Lancet Oncol"},{"key":"10.1038\/mt.2008.143_bib10","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/sj.cgt.7700902","article-title":"Oncolytic replication-competent adenovirus suppresses tumor angiogenesis through preserved E1A region","volume":"13","author":"Saito","year":"2006","journal-title":"Cancer Gene Ther"},{"key":"10.1038\/mt.2008.143_bib11","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.1200\/JCO.2005.01.3441","article-title":"Phase II study of sorafenib in patients with advanced hepatocellular carcinoma","volume":"24","author":"Abou-Alfa","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1038\/mt.2008.143_bib12","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/S0140-6736(03)14964-1","article-title":"Hepatocellular carcinoma","volume":"362","author":"Llovet","year":"2003","journal-title":"Lancet"},{"key":"10.1038\/mt.2008.143_bib13","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1053\/jhep.2003.50047","article-title":"Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival","volume":"37","author":"Llovet","year":"2003","journal-title":"Hepatology"},{"key":"10.1038\/mt.2008.143_bib14","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1053\/j.gastro.2006.01.006","article-title":"Ubiquitous activation of Ras and Jak\/Stat pathways in human HCC","volume":"130","author":"Calvisi","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1038\/mt.2008.143_bib15","doi-asserted-by":"crossref","first-page":"4033","DOI":"10.1128\/JVI.77.7.4033-4042.2003","article-title":"Tumor necrosis factor alpha inhibition of hepatitis B virus replication involves disruption of capsid Integrity through activation of NF-\u03baB","volume":"77","author":"Biermer","year":"2003","journal-title":"J Virol"},{"key":"10.1038\/mt.2008.143_bib16","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/hep.510230103","article-title":"Cytokine inhibition of the hepatitis B virus core promoter","volume":"23","author":"Romero","year":"1996","journal-title":"Hepatology"},{"key":"10.1038\/mt.2008.143_bib17","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1200\/JCO.2006.07.3049","article-title":"Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria","volume":"25","author":"Choi","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1038\/mt.2008.143_bib18","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1128\/JCM.42.2.601-609.2004","article-title":"Smallpox and pan-orthopox virus detection by real-time 3\u2032-minor groove binder TaqMan assays on the roche LightCycler and the Cepheid smart Cycler platforms","volume":"42","author":"Kulesh","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1038\/mt.2008.143_bib19","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1128\/JCM.37.9.2793-2797.1999","article-title":"Automated quantitative analysis of hepatitis B virus DNA by using the Cobas Amplicor HBV monitor test","volume":"37","author":"Noborg","year":"1999","journal-title":"J Clin Microbiol"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616320639?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616320639?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,9,13]],"date-time":"2021-09-13T04:29:24Z","timestamp":1631507364000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001616320639"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":19,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["S1525001616320639"],"URL":"https:\/\/doi.org\/10.1038\/mt.2008.143","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}